Pulmozyme

Dornase Alfa

5.1 Moderate risk

Pulmozyme & Hospitalisation

11.8%

of users reported Hospitalisation

99.1%

also reported Hospitalization

57.2%

are women

Most common medical consequences

Hospitalization

99.1%

Severe reaction

0.6%

Death

0.3%

Have you experienced any negative side effects from this medication?

Pulmozyme: general information

Most common side effects (73)

Most commonly affected ages

0 - 9 years

13.1%

10 - 19 years

34.4%

20 - 29 years

25.7%

30 - 39 years

16.0%

40 - 49 years

6.3%

50 - 59 years

1.9%

60 - 69 years

1.6%

70 - 79 years

0.4%

80 - 89 years

0.7%

On this page